Merck KGaA to invest in biosimilars, eyes pharma acquisitions

11:32 AM | May 10, 2014 | Natasha Alperowicz

Merck KGaA (Darmstadt, Germany) plans to invest €100 million ($137.6 million) this year in biosimilars, a new business being developed by its Merck Serono unit. In addition, Merck is eyeing pharma...